ALS (AMYOTROPHIC LATERAL SCLEROSIS)
Clinical trials for ALS (AMYOTROPHIC LATERAL SCLEROSIS) explained in plain language.
Never miss a new study
Get alerted when new ALS (AMYOTROPHIC LATERAL SCLEROSIS) trials appear
Sign up with your email to follow new studies for ALS (AMYOTROPHIC LATERAL SCLEROSIS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could removing excess brain iron slow down ALS?
Disease control CompletedThis small pilot study tested whether a drug called deferiprone, which removes excess iron from the body, is safe and might help slow the progression of ALS. The study involved 23 people with ALS and looked for changes in their symptoms and functional abilities over time. The mai…
Matched conditions: ALS (AMYOTROPHIC LATERAL SCLEROSIS)
Phase: PHASE2 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
Scientists search for clues in ALS Patients' blood and spinal fluid
Knowledge-focused CompletedThis study aimed to better understand Amyotrophic Lateral Sclerosis (ALS) by measuring specific proteins in the blood and spinal fluid of patients. Researchers compared samples from 60 people with early-stage ALS to samples from healthy individuals. The goal was to find biologica…
Matched conditions: ALS (AMYOTROPHIC LATERAL SCLEROSIS)
Sponsor: Ulysses Neuroscience LTD • Aim: Knowledge-focused
Last updated Mar 11, 2026 14:53 UTC